Rwanda will deploy Marburg vaccine under trial as death toll rises to 12
- Rwandan health authorities will begin a vaccine study against Marburg hemorrhagic fever as the outbreak has killed 12 people.
- Rwanda received 700 doses of a vaccine from the U.S.-based Sabin Vaccine Institute and will target health workers and responders.
- The Rwandan government reported 46 confirmed cases of Marburg, with 29 in isolation and 400 people identified as contacts of confirmed cases.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left14Leaning Right4Center16Last UpdatedBias Distribution47% Center
Bias Distribution
- 47% of the sources are Center
47% Center
L 41%
C 47%
12%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
